Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.01% | 176.96 | 0.7% | $1383.16m | |
| MRK | Merck & Co., Inc. | 0.66% | 92.50 | 0.7% | $1203.71m | |
| PFE | Pfizer Inc. | 0.55% | 50.94 | 0.9% | $1160.82m | |
| LLY | Eli Lilly & Co. | 1.74% | 323.14 | 1.1% | $1096.78m | |
| BMY | Bristol-Myers Squibb Co. | -0.53% | 78.28 | 1.0% | $1078.11m | |
| ABBV | AbbVie, Inc. | 0.96% | 153.95 | 1.9% | $992.07m | |
| AZN | AstraZeneca Plc | 1.65% | 67.02 | 1.0% | $451.24m | |
| SGEN | Seagen Inc. | 0.33% | 179.06 | 5.7% | $322.85m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.32% | 75.30 | 0.0% | $286.13m | |
| GSK | GSK Plc | 0.97% | 43.77 | 0.2% | $281.98m | |
| HZNP | Horizon Therapeutics Plc | 0.99% | 82.50 | 5.4% | $176.10m | |
| NVS | Novartis AG | 0.70% | 84.76 | 0.2% | $166.17m | |
| MRTX | Mirati Therapeutics, Inc. | -1.84% | 67.24 | 1.6% | $154.95m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.85% | 145.64 | 0.0% | $148.67m | |
| NVO | Novo Nordisk A/S | 1.63% | 110.06 | 0.1% | $146.95m |
Company Profile
Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.